A Search Service for Abbreviation / Long Form

■ 関連PubMed/MEDLINE情報

[関連PubMed/MEDLINE情報]
合計出現文献数: 63
[表示件数]
[1ページの表示件数]
ページ移動
/ ページ
略語 : RT
展開形 : reactive thrombocytosis
  
No. 発表年 題目 共起略語
2022 Cytokine pathway variants modulate platelet production: IFNA16 is a thrombocytosis susceptibility locus in humans. IFNA16, MPN, SNVs
2022 Designing a Scoring System for Differential Diagnosis From Reactive Thrombocytosis and Essential Thrombocytosis. ET
2020 Clinical course and short-term outcome of postsplenectomy reactive thrombocytosis in children without myeloproliferative disorders: A single institutional experience from a developing country. ---
2020 Total Platelet Transcriptomics and Its Network Analysis by RNA-Seq and miRNA-Seq and PCA Application in Essential Thrombocythaemia. ET, miRNAs, PCA
2019 Quantification of IGF-1 receptor is useful in the differential diagnosis of essential thrombocytosis from reactive thrombocytosis. ET, MNC
2018 A cross-sectional retrospective study to analyze the underlying causes and clinical characteristics of children with reactive thrombocytosis at a Korean tertiary medical center. ESR, KD
2018 [Risk of thrombosis in reactive thrombocytosis]. ---
2017 Assessment of procoagulant potential in patients with reactive thrombocytosis and its association with platelet count. let, vWF
2017 Extreme Thrombocytosis Presenting in Anti-Neutrophil Cytoplasmic Autoantibodies-Associated Crescentic Glomerulonephritis with Immune Complex Deposits: A Case Report. ANCA, CGN
10  2016 Do we need antiplatelet therapy in thrombocytosis? Contra. Proposal for an individualized risk-adapted treatment. ET, MPN, PV
11  2015 Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count. ACT, ET, GC, GPV, TX, vWF
12  2012 Does thrombocyte size give us an idea about thrombocytosis etiology? ET, MPV, NPV, PPV
13  2011 Associations of reactive thrombocytosis with clinical characteristics in pediatric diseases. ---
14  2011 Thrombocytosis in children. ---
15  2010 Acute myocardial infarction in a patient with post-splenectomy thrombocytosis: a case report and review of literature. ---
16  2010 [Evaluation of platelet indices for differential diagnosis of thrombocytosis by ADVIA 120]. ET, LPLT, MPC, MPM, MPV, PCT, PDW
17  2010 [Significance of platelet parameters and lactate dehydrogenase level in differential diagnosis for thrombocytosis]. CML, CMPD, ET, LDH, MPV, P-LCR, PDW, PV, ROC
18  2009 Class prediction models of thrombocytosis using genetic biomarkers. ET, RT-PCR
19  2009 Superoxide dismutase, copper and zinc concentrations in platelet-rich plasma of pneumonia patients. CAP, SOD, Zn
20  2009 The role of the Platelet Function Analyzer (PFA)-100 and platelet aggregometry in the differentiation of essential thrombocythemia from reactive thrombocytosis. CEPI, ET, NPV, PFA, PPV, Se, Sp
21  2008 Cerebral vascular accident in a patient with reactive thrombocytosis: a rare cause of stroke. ---
22  2008 Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis. AA, CT, ITP, sGPV
23  2007 [JAK2(V617F) mutation in Korean patients with essential thrombocythemia]. ET, JAK2
24  2006 Elevated platelet count before ileal pouch-anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitis. AP, CD, CP, IPAA, UC
25  2004 A standardized endogenous megakaryocytic erythroid colony assay for the diagnosis of essential thrombocythemia. BM, EEC, EMC, ET, PB
26  2003 Coexistence of chronic lymphocytic leukemia and essential thrombocythemia. CLL, ET, TPO
27  2003 Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. CRP, ESR, ET, IL1A, LDH, TNF-a
28  2003 Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia. TPO
29  2002 Circulating thrombopoietin in clonal versus reactive thrombocytosis. ET, PV
30  2002 Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia. ET
31  2002 Increased erythropoietin levels in reactive thrombocytosis. CT, EPO, TPO
32  2001 Clonality analysis using X-chromosome inactivation patterns by HUMARA-PCR assay in female controls and patients with idiopathic thrombocytosis in Taiwan. HUMARA, IT, XCIPs
33  2001 Cytokines, endothelium, and adhesive molecules in pathologic thrombopoiesis. ATP, CML, CT, ET, ICAM-1, IL, MK, MPD, PCV, TM, TNF
34  2001 Endogenous megakaryocytic colony formation and thrombopoietin sensitivity of megakaryocytic progenitor cells are useful to distinguish between essential thrombocythemia and reactive thrombocytosis. EMC, ET, MK, PV, TPO
35  2001 Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins. CRP, CT
36  2001 [Serum thrombopoietin and interleukin-6 concentration in diagnosis of thrombocytopenia]. IL-6, MPD, TPO
37  2000 Etiology and incidence of thrombotic and hemorrhagic disorders in Thai patients with extreme thrombocytosis. MPD
38  2000 Serum C-reactive protein level in postsplenectomized thalassemic patients. MPD
39  1999 Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis. CT, ELISA, IL-6, SCF, sIL-6, TPO
40  1999 Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies. ET, IMF, MPDs, PV
41  1999 Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. ET, MPDs, TPO
42  1998 Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma. BT, ET, vWF
43  1998 Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocythaemia and reactive thrombocytosis. ET, TPO
44  1997 Platelet distribution width for differential diagnosis of thrombocytosis. MPD, MPV, PDW, PLT
45  1996 Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis. CML, ET, GPIIIa, MK, MPD, PV
46  1996 The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count. ET, vWF
47  1995 Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia. ET
48  1995 Reactive thrombocytosis after coronary bypass surgery. An important risk factor. CABG, CPB
49  1995 The determination of spontaneous megakaryocyte colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis. CMLtr, ET, PRVtr
50  1994 Circulating megakaryocytic progenitor cells in patients with primary thrombocythaemia and reactive thrombocytosis: results using a serum-deprived culture assay and a positive detection technique. ---
51  1994 Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. EXT, MPD
52  1994 Primary thrombocythaemia: a composite approach to diagnosis. ATP, DF, EPO, PT
53  1993 Measurement of spleen size using gamma camera scintigraphy in essential thrombocythaemia. ET
54  1993 Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications. ET
55  1992 The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states. BM, CGL, IMF, MPDs, PT, PV
56  1991 Which tests are most useful in distinguishing between reactive thrombocytosis and the thrombocytosis of myeloproliferative disease? MPD, vWFAg
57  1990 Megakaryocyte ploidy in thrombocytosis: improved microdensitometric measurements with a new image analysis system. DNA, ET, MK, OD
58  1988 Heterogeneity of in vitro growth pattern of megakaryocyte progenitors (CFU-M) in myeloproliferative disorders. CML, ET, MPD, NH-ABCP, PV
59  1988 Platelet parameters and aggregation in essential and reactive thrombocytosis. ET, MPV, PDW
60  1988 [Thrombocyte function in essential thrombocythemia and reactive thrombocytosis]. ET
61  1985 Megakaryocytopoiesis in different forms of thrombocytosis and thrombocytopenia: identification of megakaryocyte precursors by immunostaining of intracytoplasmic factor-VIII-related antigen. AML, BM, ET, factor VIII RAg, IT, PAP
62  1985 The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases. MPD
63  1983 In vitro studies of megakaryocytopoiesis in thrombocytotic disorders of man. CFU-M, Meg-CSA, MPD